Frovatriptan; Uses, Dosage, Side Effects, Interactions

Frovatriptan; Uses, Dosage, Side Effects, Interactions

Frovatriptan is a triptan drug Serotonin-1b and Serotonin-1d Receptor Agonist for the treatment of migraine headaches, in particular, those associated with menstruation. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. It is available as 2. 5 mg tablets.

Frovatriptan is a triptan drug developed by Vernalis for the treatment of migraine headaches, in particular, those associated with menstruation. The product is licensed to Endo Pharmaceuticals in North America and Menarini in Europe. Frovatriptan causes vasoconstriction of arteries and veins that supply blood to the head. It is available as 2. 5 mg tablets.

Mechanism of Action of Frovatriptan

Frovatriptan succinate is a selective agonist of serotonin (5-hydroxytryptamine; 5-HT) type 1B and 1D receptors. Frovatriptan is structurally distinct from but pharmacologically related to, other selective 5-HT1B/1D receptor agonists (e.g., almotriptan, naratriptan, rizatriptan, sumatriptan). Because the mechanisms involved in the pathogenesis of a migraine are not clearly understood, the precise mechanism of action of 5-HT1 receptor agonists in the management of a migraine has yet to be established. However, current data suggest that 5-HT1 receptor agonists, including frovatriptan, may ameliorate a migraine through selective constriction of certain intracranial blood vessels, inhibition of neuropeptide release, and/or reduced transmission in the trigeminal pain pathway.

Frovatriptan is believed to act on extracerebral, intracranial arteries and to inhibit excessive dilation of these vessels in a migraine. Research has shown that a migraine can be caused by the swelling of blood vessels around the brain. Frovatriptan eases the pain associated with a migraine by narrowing these blood vessels. Frovatriptan has one of the highest affinities for the 5-HT1B of the second-generation triptan agonists. Frovatriptan is a second generation triptan 5-HT receptor agonist that binds with high affinity for 5-HT1B and 5-HT1Dreceptors. It is structurally distinct from but pharmacologically related to other selective 5-HT1B/1D receptor agonists. Frovatriptan has no significant effects on GABAA mediated channel activity and has no significant affinity for benzodiazepine binding sites. Frovatriptan is believed to act on extracerebral, intracranial arteries and to inhibit excessive dilation of these vessels in a migraine. Research has shown that a migraine can be caused by the swelling of blood vessels around the brain. Frovatriptan eases the pain associated with a migraine by narrowing these blood vessels. Frovatriptan has one of the highest affinities for the 5-HT1B of the second-generation triptan agonists.

You Might Also Like   Baclofen; How to Use Baclofen for Muscle Relaxant

Indications of Frovatriptan

Contra-Indications of Frovatriptan

Frovatriptan should not be given to patients with

Dosage of Frovatriptan

Strengths: 2.5 mg, 5 mg, 7.5 mg

 Migraine

Use only after a clear diagnosis of a migraine has been established

  • Initial dose: 2.5 mg orally, once
  • Provided there has been some response to the first dose, a second dose may be administered at least 2 hours later if migraine returns or symptoms recur.
  • Maximum dose: 7.5 mg in a 24-hour period.

Side Effects of Frovatriptan

The most common

More common

You Might Also Like   Top 65 Pharmacology Tips Every Student Should know

Rare

Drug Interactions of Frovatriptan

Frovatriptan may interact with the following drug, supplements, & may change the efficacy of the drug

Pregnancy Category of Frovatriptan

FDA Pregnancy Category  C

Pregnancy

This medication should not be taken during pregnancy unless the benefits outweigh the risks. If you become pregnant while taking this medication, contact your doctor immediately.

Lactation

It is not known if frovastriptan passes into breast milk. If you are a breastfeeding mother and are taking this medication, it may affect your baby. Talk to your doctor about whether you should continue breastfeeding. The safety and effectiveness of using this medication have not been established for children less than 12 years of age. Its use by people in this age group is not recommended.

You Might Also Like   Pralidoxime; Uses, Dosage, Side Effects, Interactions

References

Frovatriptan

About the author

Translate »